Microbiology Exam 4 Diseases

Réussis tes devoirs et examens dès maintenant avec Quizwiz!

AIDS Treatment

"HAART" highly active anti-retroviral therapy and cART combination anti-retroviral therapy -RT inhibitors = block RDDP and sow viral replication -Integrase inhibitors = block transformation of host genome -Protease inhibitors = block maturation/release of virus particles -Expensive, long course, resistance, efficacy unknown, doesn't treat latent

SoCVD: Ebola Virus HFVs

1) 5 species of Ebola virus : Tai Forest (Ivory Coast), Sudan, Zaire, Reston and Bundibugyo 2) Virons are filamentous (6 or U shape) 3) BUD from host cells (non-lytic) 4) People are infectious as long as their blood and secretions contain the virus

SoCVD: Septicemias P.aeruginosa: Disease Spectrum

1) ALMOST ANYTHING - adaptable and versatile 2) P.aeruginosa infections that lead to septicemia -BURN WOUND INFECTIONS -- wet, open -CYSTIC FIBROSIS INFECTIONS -- heavy mucous -NOSOCOMIAL INFECTIONS -- wet hospital 3) Other diseases of P.aeruginosa that lead to invasiveness -Endocarditis, wound infections, pneumonia, septicemia -"Swimmer's ear"/"Pseudomonas HotFoot" -Onycholysis (nail infections) -UTI, Folliculitis, bone infections -CORNEAL INFECTIONS -ECTHYMA GANGRENOSUM -- similar to NF 4) SUSCEPTIBILITY TESTING (INFECTION CONTROL AND EDUCATION)

SoCVD: HIV/AIDS and Clinical Progression

1) Clinical Stage 1 -- initial infection: VAGUE, FLU-LIKE SYMPTOMS that soon disappear (high levels --> latent) -T cell count of 500+ (asymptomatic) -2-15 years (number of T cells in blood is steadily decreasing as virus has low level replications 2) Clinical Stage 2 -- MORE NUMEROUS, BUT MILD OPPORTUNISTIC INFECTIONS (PCP, FUNGAL INF/PNEUMO) mild weight loss, sick longer -T cell count 200<x<500 3) Clinical Stage 3 -- AIDS: fatigue, diarrhea, weight loss, and neurological changes, RARE INFECTIONS OR NEOPLASMS, IMMUNODEFICIENT SYNDROMES (BURKITT'S/KAPOSI'S), protected fever, fatigue, sore throat, and night sweats, lesions in brain, meninges, spinal column, and peripheral nerves -T-cell count x<200

SoCVD: Septicemias P.aeruginosa: Epidemiology and VFs

1) G (-) = ENDOTOXIN LPS 2) LOTS of adhesion molecules 3) CAPSULE made of alginate 4) ELASTASE destroys connective tissue 5) EXOTOXIN A and EXOTOXIN S for direct tissue damage (protein synthesis inhibitors) similar to diptheria toxin 6) HIGHLY MULI-DRUG resistant 7) Lives anywhere, but prefers wet/moist environments and body locations regardless of temperature ("hot tub bug"; normal flora -- opportunistic) 8) Transmission = ANYWAY IT PLEASES -LEADING CAUSES OF NOSOCOMIAL INFECTION 9) STRICT AEROBE and always produces pigment

InfDisResp (U/LRT): Croup

1) General information and description: 2) Signs and symptoms: Mimic common cold but as infection progresses, inflammation of URT VOICEBOX AND WINDPIPE, can spread to bronchi -Leads to BARKING cough or hoarseness -When very swollen stridor squeaking noise upon inhalation -May be worse at night or when upset/crying 3) CC: PARAINFLUENZA VIRUS 4) VFs: Viral 5) Diagnosis/differentiation: Sounds, CXR with helpful ID - STEEPLE SIGN (NARROWING OF TRACHEA) 6) Treatment plan: Treat symptoms and monitor airflow/breathing, cool mist humidifiers and "outdoors" 7) Adverse effects:

InfDisResp (LRT): Pneumonia Nosocomial pneumonias HAP

1) General information and description: 2) Signs and symptoms: 3) CC: STREPTOCOCCUS PNEUMONIAE (#1 common) -Others: E.coli, S.aureus, P.aeruginosa, H.flu 4) VFs: 5) Diagnosis/differentiation: 6) Treatment plan: 7) Adverse effects:

InfDisResp (LRT): Pneumonia Community Acquired Pneumonia CAP

1) General information and description: 2) Signs and symptoms: "Rust" colored sputum common 3) CC: STREPTOCOCCUS PNEUMONIAE (#1 common) -Gram + latent shaped diplococci -Small mucoid colonies with alpha hemolysis -Others: H.flu, Neisseria spp., E.coli, S.aureus 4) VFs: Capsule 5) Diagnosis/differentiation: 6) Treatment plan: Cephalosporins 7) Adverse effects:

SoCVD: Lyme Disease EARLY LOCALIZED DISEASE

1) General information and description: 2) Signs and symptoms: Not painful, EM lesions occasionally burn or itch and are hot to tough, fatigue, neck stiffness, myalgias, arthralgias, lymphadenopathy 3) CC: 4) VFs: 5) Diagnosis/differentiation: 6) Treatment plan: 7) Adverse effects:

SoCVD: Toxic Shock Syndrome

1) General information and description: 2) Signs and symptoms: Sudden high fever and low blood pressure (hypotension) -Vomiting/diarrhea, confusion, seizures, headaches, and muscle aches -Rash resembling a sunburn particularly on palms and soles ("BOILED LOBSTER RASH"; PEELING OF SKIN ON HANDS AND FEET) 3) CC: Almost ANY bacteria can cause -STAPH AUREUS (toxemia): often associated with tampon usage or contraceptive sponges - TOXIC SHOCK SYNDROME TOXIN (TSST-1) = SUPERANTIGEN -STREP PYOGENES (bacteremia with toxemia): often introduced with puncture wounds - SPEA AND SPEC TOXINS = SUPERANTIGENS -GRAM - BACTERIA from LPS release ("septic shock" - no toxins found) 4) VFs: 5) Diagnosis/differentiation: 6) Treatment plan: 7) Adverse effects: MOF

InfDisResp (URT): Rhinitis

1) General information and description: "Common cold" 2) Signs and symptoms: Sneezing, scratchy throat, runny nose -Begin 2-3 days after infection -Generally NOT accompanied by fever -Due to immune response, not virus 3) CC: RHINOVIRUS 4) VFs: Penetrate mucous and attach to cells -Binds sialic acid residues + ICAM -Over 200+ serotypes, highly mutable 5) Diagnosis/differentiation: Appearance 6) Treatment plan: Aeresol droplet control, chicken soup and rest 7) Adverse effects:

InfDisResp (URT): Acute Otitis Media

1) General information and description: "Ear infections" 2) Signs and symptoms: Sensation of fullness or pain in the ear, loss of hearing, pus/inflammatory fluid response in the middle ear -Infections continue to Eustachian tubes 3) CC: Streptococcus pneumoniae, Haemophilus influenzae 4) VFs: CAPSULE 5) Diagnosis/differentiation: Appearance, screaming child 6) Treatment plan: NONE IS NOT PREFERRED (72 HOUR 'WATCHFUL WAITING' -B lactams -Vaccination (HiB, Pneumovax/Prevnar) 7) Adverse effects: Untreated or severe infections can lead to eardrum rupture or meningitis

SoCVD: Necrotizing Faciitis (NF)

1) General information and description: "Flesh eating disease" -Rare infection of the deeper layers of the skin and subcutaneous tissues, easily spreading across the facial plane within the subcutaneous tissue (uses bloodstream) -Death and necrosis of tissue, often requires debridement -Often after trauma 2) Signs and symptoms: Signs of inflammation may not be apparent if the bacteria are deep within the tissue 3) CC: Streptococcus pyogenes or staphylococcus aureus (toxin mediated) -NEW EMERGING CAUSE: Vibrio vulnificus (waterborne gram -) TSS connection -NEW EMERGING CAUSE: Aeromonas hydrophila (waterborne gram -) 4) VFs: 5) Diagnosis/differentiation: 6) Treatment plan: 7) Adverse effects:

SoCVD: Tularemia

1) General information and description: "RABBIT FEVER" 2) Signs and symptoms: Headache, backache, fever, chills, malaise, and weakness -Progresses to ulcerative skin lesions, swollen LN, conjunctival inflammation, sore throat, intestinal disruption, pulmonary involvement -Vector = tick bite -Most common among hunters and persons consuming infected wild game meat 3) CC: Francisella tularensis (gram -) 4) VFs: Intracellular, highly infections (ID50 = 1-10) -Potential bioweapon categoryA 5) Diagnosis/differentiation: 6) Treatment plan: Aminoglycosides (Gent, Kan) 7) Adverse effects: Debilitating, fatal if inhalation exposure

InfDisResp (URT): Pharyngitis

1) General information and description: "STREP THROAT" 2) Signs and symptoms: Inflammation of the throat, pain and swelling, reddened mucosa, swollen tonsils, bad breath, potential for white packets of inflammatory pus/products, may affect speech and swallowing 3) CC: -CC #1: Most common VIRAL (LESS SEVERE, hoarseness) -CC #2: Streptococcus pyogenes (GAS CAUSES 1/3 PHARYNGITIS - NF BUT ACTIVE IS BEST SPREAD CHANCE) -CC #3: FUSOBACTERIUM NECROPHORUM - gram neg rare (young), idential to GAS but reported as "non-GAS" 4) VFs: -M PROTEIN (1, 3, 5, 6, 12, 18, 19, 24) with adhecin and WBC evasion mechanism and responsible for serotype and sequelae determinant -CC #2: look at other slides 5) Diagnosis/differentiation: Appearance, rapid strep testing 6) Treatment plan: -CC #3: PEN BUT NOT Z PACKS -CC #2: B-lactams with anti B-lactamase (Augmentin) 7) Adverse effects: -CC #2: look at other slides -CC #3 can lead to Lemierre's syndrome (blood infection)

InfDisResp (URT): Sinusitis

1) General information and description: "Sinus infection" 2) Signs and symptoms: Nasal congestion, pressure above nose or in forehead, feeling of headache or toothache, facial swelling/tenderness common -Often follow common cold -WHITE, BROWN, GREEN, OR YELLOW COLOR OPAQUE DISCHARGE (bacterial) 3) CC: Bacterial, viral, and fungal agents -NORMAL FLORA (RECURRENCE) 4) VFs: BIOFILMS, PERSISTENCE, MIXED INFECTIONS 5) Diagnosis/differentiation: Appearance, occasional radiology 6) Treatment plan: BROAD SPEC antibiotics (Z pack, augmentin, erythro) 7) Adverse effects:

InfDisResp (LRT): Common Fungal Pneumonias ASPERGILLUS FUMIGATIS

1) General information and description: "The black mold" - can be normal flora or opportunistic pathogen -Large increase in AIDS patients 2) Signs and symptoms: Systemic aspergillosis - black lesions 3) CC: 4) VFs: 5) Diagnosis/differentiation: Appearance - "septate branching hyphae" LIGHTING AND BROCCOLI 6) Treatment plan: Azoles, ampho b 7) Adverse effects: Pneumonia, lung infection

InfDisResp (LRT): Atypical Pneumonia

1) General information and description: "Walking pneumonia" 2) Signs and symptoms: Asymptomatic to mild cough and malaise to fever, muscle ache, severe fatigue 3a) CC/VF #1: -CC #1: CHLAMYDIA PNEUMONIAE - gram n/a -VF #1: OBLIGATE INTRAcellular; ID biphasic lifecycle 3b) CC/VF #2 -CC #2: MYCOPLASMA PNEUMONIAE - gram n/a -VF #2: OBLIGATE EXTRAcellular (TIP ADHESION STRUCTURE) - lack PPG so no cell wall; smallest free-living bacterium; ID colonies grow slow and resemble fried eggs 5) Diagnosis/differentiation: Symptomatic 6) Treatment plan: Macrolides or tetracyclines 7) Adverse effects: Repeated infections correlated with increased risk of atherosclerosis

InfDisResp (U/LRT): Pertussis

1) General information and description: "Whooping cough" -LONG recovery phase of weeks/months (secondary infection with other microorganisms) -OBLIGATE pathogen -Aerosol transmission -HIGHLY contagious 2) Signs and symptoms: Appears with cold-like symptoms, progresses to PAROXYSMAL stage -Severe and uncontrollable coughing usually with a whoop sound, but may be absent in infants 3) CC: Bordetella pertussis (G - coccobacilli) 4) VFs: Toxins -TRACHEAL CYTOTOXIN (CT): AB toxin, kills ciliated nasopharynx cells -PERTUSSIS TOXIN (PT): upregulate cAMP in cells by blocking the inhibitory subunit of the G protein responsible for downregulation of cAMP - REVERSE EFFECT 5) Diagnosis/differentiation: Sound, throat culture 6) Treatment plan: Z pack starting point, Erythromycin, vaccine (DPT) - 5 BOOSTERS 7) Adverse effects: Violent coughing spasms can result in burst blood vessels in the eyes, vomiting, cracked ribs

InfDisResp (LRT): Tuberculosis

1) General information and description: #1 INFECTIOUS CAUSE OF DEATH WORLDWIDE; FOREIGN BORN 2) Signs and symptoms: 3) CC: Mycobacterium tuberculosis or mycobacterium avium intracellulare (MAC) 4) VFs: "CORD FACTOR" and proton pump = allow INTRACELLULAR growth 5) Diagnosis/differentiation: Gram N/A with heavy lipid content -"ACID FAST" staining (slim red snapper rods with segmentation) -"BREADCRUMB" colonies -Tuberculin testing (PPD) -Chest x-rays (CXR) -Direct identification of acid-fast bacilli (AFB) -Culture isolation + antimicrobial susceptibility testing -"Quant-iFeron GOLD" 6) Treatment plan: 7) Adverse effects:

InfDisResp (LRT): Common Fungal Pneumonias HISTOPLASMA CAPSULTUM

1) General information and description: Acquired from bird droppings, bat caves, and some SOIL locations -ENDEMIC (rural population from field plowing and chicken coops) -Causes lung mycosis with slower progression to pneumonia disease (asymptomatic or cold-like) 2) Signs and symptoms: 3) CC: 4) VFs: 5) Diagnosis/differentiation: SMALL, OVAL BUDDING YEASTS INSIDE MO -Lung disease can appear as "SNOWSTORM" CXR 6) Treatment plan: Azoles, ampho b 7) Adverse effects: Suspect disseminated histoplasmosis in HIV cases

SoCVD: Lyme Disease EARLY DISSEMINATED DISEASE

1) General information and description: Acute neurologic or cardiac involvement usually occurs weeks to several months after the tick bite Bilateral cranial nerve palsies 2) Signs and symptoms: Meningitis, cranial neuropathy, motor or sensory radiculoneuropathy facial never affected, bilateral cranial nerve palsies, conjunctivitis 3) CC: 4) VFs: 5) Diagnosis/differentiation: 6) Treatment plan: Tetracycline, doxycycline, prevent from spreading 7) Adverse effects:

InfDisResp (LRT): Pneumonia

1) General information and description: Anatomical diagnosis -Inflammatory condition of the lung in which liquid fills the alveoli 2) Signs and symptoms: -Begin with upper respiratory tract symptoms, runny nose and congestion and fever -Onset of lung symptoms: chest pain, fever, cough, discolored sputum 3) CC: WIDE VARIETY OF MICROORGANISMS -Almost any bacteria -Viral pneumonias are usually milder than bacterial 4) VFs: 5) Diagnosis/differentiation: 6) Treatment plan: 7) Adverse effects:

SoCVD: Cat-Scratch Fever and Cat-Bite Cellulitis

1) General information and description: Any animal wound -Starts as classic cellulitis - hot, tight reddened INFLAMMATION underskin lesions w occasional cluster of small papules -Moves to capillaries or lymphatics - swollen lymph nodes with pus ('tracks' up vessels in limbs) 2) Signs and symptoms: 3) CC: -C.S.Fev = Bartonella henselae (gram - intracellular) -C.B.Cel = Pasturella multocida (gram - coccobacilli w bipolar safety pin staining, CAPSULE, P.multocisa toxin destroys connective tissue and allows for invasion) 4) VFs: 5) Diagnosis/differentiation: 6) Treatment plan: Most simple cellulitis is self-limiting, some require antibiotics -Immunocompromised need aggressive therapy 7) Adverse effects: -Immunocompromised risk systemic spread -BACILLARY ANGIOMATOSIS - vascularproliferative disease (blood blisters) -BACILLARY PELIOSIS HEPATITIS - blood-filled cavities in liver -ENDOCARDITIS - moving through blood stream

InfDisResp (LRT): Bronchitis

1) General information and description: As the inflammation of the bronchial tubes progresses = excessive mucus production, chest pains, heavy breathing, SOB and wheezing -Must R/O for PNEUMONIA -Having symptoms for loner terms (3+mo) confirm it to be chronic 2) Signs and symptoms: Extreme coughing, nasal congestion, fever, fatigue 3) CC: -CC #1: VIRUS INFECTION (influenza, RSV, hMPV) -CC #2: BACTERIAL INFECTION (S.pneumonia, H.influenzae, Mycoplasma, Klebsiella) -CC #3: ENVIRONMENTAL/IMMUNOLOGICAL (smoke, allergens, pollutants, irritants) 4) VFs: 5) Diagnosis/differentiation: Bronchial wash to find agent, CXR 6) Treatment plan: Normally self-limiting, but severe infection may need admission for O2, IV fluids, ventilation -Symptomatic treatment with inhalers (albuterol, bronchodilators or occasionally steroidal) 7) Adverse effects: Pneumonia

SoCVD: Plague

1) General information and description: BUBONIC PLAGUE "black death" -Bacterium injected through a flea bite -Lymphatic infection, causes inflammation an necrosis of the LN -SEPTICEMIC PLAGUE: when the case progresses to massive bacterial growth in the blood -PNEUMONIC PLAGUE: respiratory disease -ENDEMIC to W/SW US -From fleas, contact with wild animals 2) Signs and symptoms: -Swollen lesion called BUBO usually in the groin or axilla -Fever, chills, headache, nausea, weakness, and tenderness of the bubo, DIC, subcutaneous hemorrhage/purpura, tissue necrosis 3) CC: Yersinia pestis (gram -) 4) VFs: low ID (3-50), Top T3SS ("syringe injector") 5) Diagnosis/differentiation: 6) Treatment plan: Aminoglycoside antibiotics, vaccine available for high risk individuals 7) Adverse effects: HIGH mortality -- death in 2-4 days

InfDisResp (U/LRT): Influenza

1) General information and description: Begins in the URT -Virus replication --> cell death --> sloughing of cells into airway and inflammation (acute confines infection of virus; H1N1) -Cell breakdown products + CYTOKINE STORM responsible for SYSTEMIC SYMPTOMS 2) Signs and symptoms: Rapid onset, headache, chills, dry cough, body aches, FEVER (BUT H1N1 VARIABLE), stuffy nose, and sore throat from draining 3) CC: Influenza virus (Orthomyxovirus) types A and B 4) VFs: Mutability, HEMAGGLUTININ (HA) and NEURAMINIDASE (NA) CAPSID PROTEINS -Spikes for attachment and entry to host cells -HxNx typing 5) Diagnosis/differentiation: Symptomatic, very few further testings although H/N typing is increasing 6) Treatment plan: Infections are self limiting, but severse infection may give antivirals (Relenza, Tamiflu) "BEST GUESS" vaccine yearly for anyone +6mo (INACTIVE) or LAIV (FluMist, 5yr+) for mucosal protection 7) Adverse effects: Serious cases may also affect the LRT (SECONDARY BACTERIAL INFECTION)

SoCVD: Ebola Virus

1) General information and description: CURRENT OUTBREAK = INTENSE VIREMIA -Spread blood/secretion/needle/close contact -Quicker spread through hospital (aerosol) 2) Signs and symptoms: Fever, headache, joint/muscle aches, weakness, diarrhea, vomiting, stomach pain, lack of appetite -Rash, red eyes, hiccups, cough, sore throat, chest pain, difficulty breathing, difficulty swallowing, impaired kidney and liver function 3) CC: Ebola virus, marburg virus (- sense RNA) 4) VFs: Unknown 5) Diagnosis/differentiation: Low white blood cell and platelet counts and elevated liver enzymes 6) Treatment plan: No known beyond supportive 7) Adverse effects: AGGRESSIVE VIREMIA = clotting (DC) leading to bleeding inside/outside of the body -LETHALITY ~50-90%

InfDisResp (LRT): Aggressive Pneumonias Pontiac Fever

1) General information and description: Caused by breathing in weakened or dead L.pneumo bacteria -"Simple/regular" pneumonia only -Water aerosol only 2) Signs and symptoms: 3) CC: Legionella pneumophila (gram -) 4) VFs: HIGHLY virulent; lives in water (A/C cooling towers, water storage, sprinkler systems - chlorine resistant) 5) Diagnosis/differentiation: CBYE agar 6) Treatment plan: Immediate antibiotics 7) Adverse effects:

SoCVD: Zika Virus Microcephaly

1) General information and description: Condition where baby's head is much smaller than expected (baby's brain has not developed properly) -GREATER TISK DURING 1ST TRIMESTER -Isolated or in combination with other birth defects 2) Signs and symptoms: Seizures, developmental delay, problems with speech and other developmental milestones, intellectual disability, movement and balance problems, feeding problems, hearing loss, vision problems 3) CC: 4) VFs: RECEPTOR PROTEIN AXL (normally involved in cell vision in developing human brain cells) -- not only protein linked to Zika 5) Diagnosis/differentiation: 6) Treatment plan: 7) Adverse effects:

SoCVD: Dengue Fever

1) General information and description: GLOBAL INCIDENCE HAS GROWN DRAMATICALLY IN RECENT DECADES 2) Signs and symptoms: SUDDEN HIGH FEVER (104-105 @ 4-7 days after mosquito bite) -FLAT, RED RASH -SECOND RASH measles like -INCREASED SKIN SENSITIVITY and VERY UNCOMFORTABLE ("BONEBREAK FEVER") 3) CC: Dengue virus (+RNA virus) 4) VFs: Viral, mosquito borne, high titer VIREMIA -Increased virulence due to ANTIBODY DEPENDENT ENHANCEMENT OF VIRAL REPLICATION 5) Diagnosis/differentiation: 6) Treatment plan: 7) Adverse effects: MORE SEVERE DISEASE UPON RE-EXPOSURE -Hemorrhagic bleeding

InfDisResp (URT): Diphtheria

1) General information and description: Infection with sore throat, lack or appetite or low-grade fever 2) Signs and symptoms: -PSEUDOMEMBRANE forms on the tonsils or pharynx, ASPHYXIATION -Systemic - toxin attacks CNS and cardiac tissue 3) CC: Corynebacterium diphtheriae (G + rod) 4) VFs: TOXIN - NO invasion -- A/B toxin attacks protein synthesis 5) Diagnosis/differentiation: -Gram stain of "chinese character" or "XY pattern", ELEK TEST, Tinsdale agar (black colonies) -Appearance, rapid strep test 6) Treatment plan: ANTI-TOXIN + PEN or ERY, vaccine (DPT) 7) Adverse effects: Extreme fatigue, dementia, and eventual death that looks very much like an MI (dead cardiac tissue)

SoCVD: Endocarditis

1) General information and description: Inflammation of the endocardium, usually referring to an infection of the valves of the heart -MICROBE ATTACHMENT AND GROWTH ("VEGETATIONS") -May follow infection of any prosthetic devices (catheters, joint replacements, artificial heart valves) or drug use 2) Signs and symptoms: Fever, anemia, abnormal heartbeat, symptoms similar to heart attack, petechiae rash (Osler's nodes/Janeway lesions) and under the fingernails (splinter hemmorage) may be present 3) CC: Staphylococcus epidermidis (Coag-neg Staph) -CC #2: Oral Streptococci (S.mutans or S.oralis) -CC #3: "high power" pathogens like S.aureus, GAS, etc 4) VFs: Biofilm formation 5) Diagnosis/differentiation: (-) for coagulase enzyme 6) Treatment plan: Complete removal of prosthetic, long term antibiotics 7) Adverse effects:

SoCVD: Infectious Mononucleosis

1) General information and description: Mono "kissing disease" 2) Signs and symptoms: MANY ONLY COLD LIKE SYMPTOMS -SORE THROAT, high fever, lymphadenopathy -Gray-white exudates in throat, skin rash, enlarged spleen/liver -Sudden leukocytosis -Fatigue -Bells palsy 3) CC: EPSTEIN-BARR VIRUS (EBV) 4) VFs: Infects B-cells, latency 5) Diagnosis/differentiation: 6) Treatment plan: None, rest, no heavy exercise or intimate contact 7) Adverse effects: -Spleen damage/rupture -Potential reactivation as Burkitt's lymphoma (B-cell cancer)

InfDisResp (URT): Enterovirus D68

1) General information and description: More severe than common cold -"Summer colds" or "pre-flu" 2) Signs and symptoms: Sneezing, scratchy throat, runny nose -Low grade fever 3) CC: ENTEROVIRUS STRAINS -Endogenous and exogenous infection 4) VFs: Viral -100+ serotypes 5) Diagnosis/differentiation: Appearance 6) Treatment plan: Aerosol droplet control, chicken soup, rest -Watch/educate about respiratory collapse -Supportive care 7) Adverse effects: Serious for immunocompromised

InfDisResp (U/LRT): RSV infection

1) General information and description: Most prevalent cause of respiratory infection in newborn age group 2) Signs and symptoms: Fever lasting ~3 days, rhinitis, pharyngitis, and otitis 3) CC: RESPIRAORY SYNCYTIAL VIRUS (RNA VIRUS) 4) VFs: Produces giant multinucleated cells (SYNCTIA) -"TRIPLE WHAMMY OF RSV" = syncytial + inflamm + remodeling 5) Diagnosis/differentiation: Bronchial or nasal wash to find syncytial cells 6) Treatment plan: Mild infections are self-limiting, but severe infection may need admission for O2, IV fluids, ventilation, and antivirals (RIBAVIRIN) 7) Adverse effects: -More serious infections give symptoms of croup like coughing, wheezing, dyspnea, rales -Severe disease under age 6 mo - easily spread by adults (LRT involvement; pneumonia; "blueing" from airway inflammation)

InfDisResp (LRT): Aggressive Pneumonias LEGIONNAIRES DISEASE

1) General information and description: Multifocal necrotizing pneumonia 2) Signs and symptoms: Headache, fever, chills, non productive cough --> Multifocal necrotizing pneumonia (productive cough, chest pain, vomiting, confusion/delerium, diarrhea) 3) CC: 4) VFs: 5) Diagnosis/differentiation: 6) Treatment plan: 7) Adverse effects: SHOCK, MOF, DEATH, MORTALITY RATE ~50%

SoCVD: Lyme Disease LATE DISEASE

1) General information and description: Occurs moths to a few years after onset infection and may not be preceded by a history of early localized or disseminated lyme disease 2) Signs and symptoms: Arthritis, mild neurologic syndrome called lyme encephalopathy 3) CC: 4) VFs: 5) Diagnosis/differentiation: 6) Treatment plan: 7) Adverse effects:

SoCVD: Septicemias

1) General information and description: Occurs when organisms actively multiplying in the blood 2) Signs and symptoms: FEVER and HYPOTENSION are prominent symptoms -Ill, low blood pressure, may have an altered mental state, shaking, chills, gastrointestinal symptoms, increased breathing rate and respiratory alkalosis 3) CC: MANY DIFFERENT BACTERIA and a few FUNGI can cause this condition (GAS and PSEUDOMONAS AERUGINOSA) 4) VFs: 5) Diagnosis/differentiation: P.aerug grows on almost any media, colonies are GREENISH or BLUISH color, "FRUITY" or "GRAPE-LIKE" odor -Identify by FLORESCENCE (+) and OXIDASE testing (+) 6) Treatment plan: Treat aggressively with several antibitotics 7) Adverse effects:

InfDisResp (U/LRT): Coronaviruses "Middle East Respiratory Syndrome" MERS

1) General information and description: Person to person, close contact spread, rapid progressions 2) Signs and symptoms: Mild cough/resp/cold-like to SWIFT, SEVERE ACUTE RESPIRATORY COLLAPSE -Fever, cough, shortness of breath 3) CC: NOVEL CORONAVIRUS or MERS-COV 4) VFs: Unknown -Super spreaders -Poster children for rapid transmission/pandemic 5) Diagnosis/differentiation: Lab tests for MERS-CoV 6) Treatment plan: Supportive to relieve symptoms 7) Adverse effects: Eventual progression to LRT and pneumonia or pneumonia-like symptoms -MERS mortality ~50%

InfDisResp (U/LRT): Coronaviruses "Sudden Acute Respiratory Syndrome" (SARS)

1) General information and description: Person to person, close contact spread, rapid progressions 2) Signs and symptoms: Mild cough/resp/cold-like to SWIFT, SEVERE ACUTE RESPIRATORY COLLAPSE -Fever, cough, shortness of breath 3) CC: SARS CORONAVIRUS 4) VFs: Unknown -Super spreaders -Poster children for rapid transmission/pandemic 5) Diagnosis/differentiation: 6) Treatment plan: Supportive to relieve symptoms 7) Adverse effects: Eventual progression to LRT and pneumonia or pneumonia-like symptoms -SARS mortality ~15% (immunocomp/elderly)

InfDisResp (LRT): Common Fungal Pneumonias PNEUMOCYSTIS JIROVECII

1) General information and description: Pneumocystis pneumonia (PCP) or pneumocystosis -Lower sputum than other pneumonias unless secondary bacterial infection -RECENT LARGE INCREASE IN HIV/AIDS PATIENTS 2) Signs and symptoms: Most cases begin cold-like but progress uncontrolled 3) CC: 4) VFs: 5) Diagnosis/differentiation: HIV test; appearance "crushed pingpong balls" on methenamine silver strain 6) Treatment plan: Azoles, ampho b 7) Adverse effects:

InfDisResp (LRT): Pneumonia KLEBSIELLA PNEUMONIAE CRKP

1) General information and description: Pneumonia, bloodstream infections, would or surgical site infections, meningitis, infections via ventilators or IV catheters, and patients extended antibiotic regimens 2) Signs and symptoms: 3) CC: Gram - bacillus, normal flora of gut and feces 4) VFs: -Highly mucoid carbohydrate capsule ("string test") -Production of carbapenemase enzyme (BLAKPC OR NDM-1) 5) Diagnosis/differentiation: RED JELLY LOOKING 6) Treatment plan: -Increasing antibiotic resistance to carbapenem class 7) Adverse effects: High rates of morbidity and mortality (prolonged hospitalization)

SoCVD: Lyme Disease

1) General information and description: Rash disease spread by ticks -Evolves into a slowly progressive syndrome that mimics neuromuscular and rheumatoid conditions -STAGES 2) Signs and symptoms: "Post lyme disease syndrome" - headache, fatigue and arthralgias that may persist for months after treatment (symptoms improve gradually over 6mo-1 year) 3) CC: Borrelia burgdorferii (spirochete) 4) VFs: Motility, adhesion, antigen shifting 5) Diagnosis/differentiation: 6) Treatment plan: Doxycycline or b-lactams (1st), Cefotaxime or ceftriaxone (2nd) -Administered ~3-4 weeks -Corticosteroids for inflammatory 7) Adverse effects:

InfDisResp (LRT): Aggressive Pneumonias HANTAVIRUS

1) General information and description: SPREAD BY RODENT DROPPINGS but PERSON TO PERSON TRANSMISSION POSSIBLE -Respiratory --> pneumonia --> dead 2) Signs and symptoms: 3) CC: 4) VFs: 5) Diagnosis/differentiation: FROM CDC 6) Treatment plan: 7) Adverse effects: Hantavirus Pulmonary Syndrome HPS -Cytokine storm -Large edema formation due to massive immune response -40% mortality rate

SoCVD: Zika Virus

1) General information and description: Spread through mosquitos, sexual transmission, perinatal, in utero, transfusion transmission -NOT LIKELY CARRIES/CHRONIC -NOT DEADLY -MOST WON'T KNOW THEY HAVE DISEASE BECAUSE ASYMPTOMATIC -SUBCLINICAL HAS NOT BEEN ASSOCIATED WITH SERIOUS CONSEQUENCES YET 2) Signs and symptoms: Similar to dengue and chikungunya -Fever, rash (maculopapular), joint pain, conjunctivitis w possible muscle pain and headache (MILD) 3) CC: ZIKA VIRUS (SSRNA, FLAVIVIRIDAE FAMILY) 4) VFs: LIPID MEMBRANE, NEUROTROPHIC? -VECTOR-BORNE VIA ANDES SPP MOSQUITOS, PRIMATE AND NON-HUMAN RESERVOIRS 5) Diagnosis/differentiation: 6) Treatment plan: No vaccine to prevent but treat symptoms with rest, fluids, tylenol/fever reducers, no aspirin 7) Adverse effects: -Guillain-Barre Syndrome -Microencephaly in developing baby -Autoimmune disorder - acute disseminated encephalomyelitis, resembling MS with additional edema of brain and spinal cord

SoCVD: Ehrlichiosis

1) General information and description: Tick bite disease 2) Signs and symptoms: Mimics RMSF -- sustained fever, chills, headache, muscle pain -USUALLY NO RASH 3) CC: -E.chaffiensis (HME) - Human Monocytic Ehrlichia (Mo, DC) -E.equi (HGE) - Human Granulocytic Ehrlichia (No, Masts, etc) -Identical infections but infect DIFFERENT IMMUNE CELL TYPES 4) VFs: Intracellular pathogen 5) Diagnosis/differentiation: 6) Treatment plan: Tetracycline, limit tick exposure and proper removal/disinfection 7) Adverse effects: Cardiovascular disruption, restlessness, delirium, convulsions, tremor, coma

SoCVD: Rocky Mountain Spotted Fever (RMSF)

1) General information and description: Tick bite disease 2) Signs and symptoms: Sustained fever, chills, headache and muscle pain -SPOTTED RASH within 2-4 days (spread FROM EXTREMITIES TO TRUNK) -Cardiovascular disruption, restlessness, delirium, convulsions, tremor, and coma 3) CC: Rickettsia rickettsii 4) VFs: Obligate intracellular pathogen -REPLICATED IN ENDOTHELIAL CELLS (blood vessel lining) 5) Diagnosis/differentiation: 6) Treatment plan: Tetracycline, limit tick exposure and proper removal/disinfection 7) Adverse effects: 20% MORTALITY RATE IF UNTREATED -Kidney failure, GI problems, heart complications

SoCVD: Malaria

1) General information and description: Vector-borne transmission (mosquitoes) 2) Signs and symptoms: Cyclic fevers (fever-chills-fever-chills), anemia, fatigue 3) CC: Plasmodium falciparum (parasite) 4) VFs: None known 5) Diagnosis/differentiation: "CIRCLES" -- ring form, schizonts -"thick and thin" blood smears 6) Treatment plan: Quinine (expensive) or with mosquito netting/repellents and water source cleanup 7) Adverse effects: Neurological damage (high intracranial pressure) and abnormal posturing in kids

InfDisResp (U/LRT): Metapneumovirus

1) General information and description: hMPV -Most common in children and older adults (acute respiratory tract infection that is found commonly as INFLUENZA NEGATIVE, RSV NEGATIVE) 2) Signs and symptoms: Similar to Influenza: rapid onset headache, chills, dry cough, body aches, fever, stuffy nose, and sore throat 3) CC: Metapneumovirus (Paramyxovirus) 4) VFs: Unknown 5) Diagnosis/differentiation: DFA, (direct immunofluorescence) PCR 6) Treatment plan: Treat symptoms, not virus 7) Adverse effects:

InfDisResp (LRT): Tuberculosis Issues of Antibiotic Resistance

1) High levels of patient noncompliance are common due to long course treatments -DIRECTLY OBSERVED THERAPY (DOTs) -Incarceration also an option but a cause 2) MDR-TB (MULTIDRUG-RESISTANT TB) 3) XDR-TB (EXTENSIVELY DRUG-RESISTANT TB) 4) TDR-TB (TOTALLY DRUG RESISTANT TB)

InfDisResp (U/LRT): Influenza Variation

1) Influenza virus (Orthomyxovirus) Types A and B -SEGMENTED genome of 8 strands of RNA -Allows reassortment of fragments + mutations 2) Yearly flu strain changes (mutations) = ANTIGENIC DRIFT -Minor mutations in H, N, or both -Reduced host immune response to virus -Produces most seasonal influenza strains 3) Epidemic strain changes (reassortment) = ANTIGENIC SHIFT -"Shuffling" of genome in multiple virus infected hosts, RNA exchange between different viruses -More likely to produce pandemic strains or lead to new strains (H1N1 or H5N1)

InfDisResp (LRT): Tuberculosis THREE STAGES

1) Primary: Initial infection that is controlled and goes dormant -'Flulike' with mild fever -Positive for PPD, negative for CXR - not very contagious -FORMATION OF GRANULOMAS/TUBERCLES = hard calcified lesions of infected cells and M.tb (DORMANCY); lower central areas of the lungs as granulomas -ID50 ~ 10 -Mo ingest M.tb which then escape the phagolysosomal destruction -Killing of CD*+ T cells needed, leaves cell debris, need for more Mo -More M.tb infection 2) Secondary: Active infection, contagious, reactivations -Fever, coughing with BLOOD TINGED SPUTUM, NIGHT SWEATS, WEIGHT LOSS -"Consumption" -Positive for PPD and CXR -REACTIVATION/ESCAPE causes large immune response mediated by T cells; EXTENSIVE INFILTRATION in upper lungs/bronchi and marked tubercles -Cytokine release from Tcells results in CASEOUS (LIQUIFYING) NECROSIS "COTTAGE CHEESE LUNG") and spread out to lungs to other tissues 3) Disseminated (Miliary or "Pots Disease"): Spread of M.tb out of lungs to other tissues -Destructive lesions in spine and bone structure, humps, etc

InfDisResp (URT): Pharyngitis S pyogenes: Complications of Strep Throat

1) Scarlet Fever -Erythrogenic toxin production -Sandpaper like rash and high fever, school aged children 2) Rheumatic fever -X reaction between streptococcal M protein and heart muscle -Occurs about 3 weeks after pharyngitis has subsided -Damage to heart valves and circulatory system, arthritis in many joints 3) Glomerulonephritis -Formation of antigen-antibody complexed in the glomeruli (T3HS) -Characterized by nephritis and kidney failure/function 4) TSS and necrotizing fasciitis

InfDisResp (LRT): Tuberculosis Treatment and Prevention

1) Sunshine and outdoors (heat and UV sensitive) 2) "Cocktail treatment": LONG TERM treatment with antibiotics -RISE = rifampin, isoniazid, streptomycin, and ethambutol -Now adding pyrazinamide (RIPES) + aminoglycosides (RIPESAg) -NON-COMPLIANCE -- antibiotic resistance problematic 3) Prevention: education and detection 4) Vaccine: Bacille-Calmette-Guerin (BCG) -Not used in US

InfDisResp (URT): Pharyngitis S pyogenes: VFs

1) Surface antigens -LIPOTEICHOIC ACID (LTA) -M PROTEIN -HYALURONIC ACID (HA) 2) Extracellular Toxins -STREPTOLYSINS: streptolysin O (SLO) and streptolysin S (SLS) for hemolysis -ERYTHROGENIC TOXIN: rash, fever typical of scarlet fever 3) Superantigens -SPEA/SPEC activate T cells and induce tumor necrosis factor cytokine-mediated damage

SoCVD: Ebola Virus HEMORRHAGIC FEVER VARIANTS

1) Viral protein involvements 2) Coagulation abnormalities (GI bleeding, rash, hematological irregularities such as lymphopenia and neutrophilia) -Cytokines released when reticuloendothelial cells encounter virus --> exaggerated inflammatory response not protective -Damage to liver, massive viremia --> DIC blocking blood flow -Virus eventually infects microvascular endothelial cells and compromised vascular integrity (terminal stages include diffuse bleeding and hypotensive shock)

InfDisResp (U/LRT): Influenza Vaccination

Best Prevention: Hygiene + vaccination 1) Inactivated seasonal vaccine (injection) -3-5 different viruses resembling variants predicted in the coming flu season (70-90% effective against those strains) -6 mo+ -Standard side effects and risks 2) Live attenuated seasonal vaccine (LAIV): FluMist -Stimulates secretory immunity, but not as effective as we had hoped -5-49 years 3) Intradermal vision vaccine (FluZone ID) -2-3 viruses, efficacy is protective but % unknown -5-60 years -Higher side effects, same risks, LESS antigen, thimerosal (Hg) FREE


Ensembles d'études connexes

NUR 1068 Health Assessment- Ch 1 - collecting and analyzing data

View Set

bio 111 final (all unit quizzes)When a car burns gasoline, much of the energy is released in the form of heat. Which of the following best describes this process in relation to the first law of thermodynamics?

View Set

Unit 1- Foodborne Illnesses & Their Sources

View Set

Physical Geography Ch 2, Physical Geography- Chapter 2 Reading, GY 101 Chapter 2 (a)(b) Learnsmarts, Chapter 2, Geo2

View Set